Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Meschiari, Marianna"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-19 z 19
    Tytuł:
    A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients.
    Autorzy:
    Alteri C; Multimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCS, Rome, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
    Fox V; Multimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCS, Rome, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
    Scutari R; Multimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCS, Rome, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
    Burastero GJ; Department of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
    Volpi S; Department of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
    Faltoni M; Department of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
    Fini V; Multimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCS, Rome, Italy.
    Granaglia A; Multimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCS, Rome, Italy.
    Esperti S; Department of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
    Gallerani A; Department of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
    Costabile V; Multimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCS, Rome, Italy.
    Fontana B; Department of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
    Franceschini E; Department of Infectious Diseases, AOU Modena, Modena, Italy.
    Meschiari M; Department of Infectious Diseases, AOU Modena, Modena, Italy.
    Campana A; Academic Department of Pediatrics, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
    Bernardi S; Academic Department of Pediatrics, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
    Villani A; Academic Department of Pediatrics, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
    Bernaschi P; Multimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCS, Rome, Italy.
    Russo C; Multimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCS, Rome, Italy.
    Guaraldi G; Department of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
    Mussini C; Department of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
    Perno CF; Multimodal Research Area, Microbiology and Diagnostics of Immunology Unit, Bambino Gesù Children Hospital IRCCS, Rome, Italy. .
    Pokaż więcej
    Źródło:
    Communications biology [Commun Biol] 2022 Dec 15; Vol. 5 (1), pp. 1376. Date of Electronic Publication: 2022 Dec 15.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    SARS-CoV-2*/genetics
    COVID-19*
    Humans ; COVID-19 Drug Treatment ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Evolution, Molecular
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection.
    Autorzy:
    Mussini C; Department of Infectious Diseases, Azienda Ospedaliero-Universitaria, Policlinico of Modena, Modena, Italy.; Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Cozzi-Lepri A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL Population Health Sciences, University College London, London, United Kingdom.
    Menozzi M; Department of Infectious Diseases, Azienda Ospedaliero-Universitaria, Policlinico of Modena, Modena, Italy.
    Meschiari M; Department of Infectious Diseases, Azienda Ospedaliero-Universitaria, Policlinico of Modena, Modena, Italy.
    Franceschini E; Department of Infectious Diseases, Azienda Ospedaliero-Universitaria, Policlinico of Modena, Modena, Italy.
    Milic J; Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Brugioni L; Internal Medicine Department, Azienda Ospedaliero-Universitaria, Policlinico of Modena, Modena, Italy.
    Pietrangelo A; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
    Girardis M; Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Department of Anaesthesia and Intensive Care Unit, Azienda Ospedaliero-Universitaria, Policlinico of Modena, Modena, Italy.
    Cossarizza A; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
    Tonelli R; Respiratory Diseases Unit, Azienda Ospedaliero-Universitaria, Policlinico of Modena, Modena, Italy.
    Clini E; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.; Respiratory Diseases Unit, Azienda Ospedaliero-Universitaria, Policlinico of Modena, Modena, Italy.
    Massari M; Infectious Disease Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
    Bartoletti M; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
    Ferrari A; Infectious Disease Unit, Azienda Ospedale, University of Padua, Padua, Italy.
    Cattelan AM; Infectious Disease Unit, Azienda Ospedale, University of Padua, Padua, Italy.
    Zuccalà P; Department of Public Health and Infectious Disease, Sapienza University of Rome, Polo Pontino, Italy.
    Lichtner M; Department of Public Health and Infectious Disease, Sapienza University of Rome, Polo Pontino, Italy.
    Rossotti R; Niguarda Hospital Milan, Milano, Italy.
    Girardi E; National Institute for Infectious Diseases L. Spallanzani (INMI), Rome, Italy.
    Nicastri E; National Institute for Infectious Diseases L. Spallanzani (INMI), Rome, Italy.
    Puoti M; National Institute for Infectious Diseases L. Spallanzani (INMI), Rome, Italy.; School of Medicine, Università degli studi di Milano Bicocca, Milano, Italy.
    Antinori A; National Institute for Infectious Diseases L. Spallanzani (INMI), Rome, Italy.
    Viale P; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
    Guaraldi G; Department of Infectious Diseases, Azienda Ospedaliero-Universitaria, Policlinico of Modena, Modena, Italy.; Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2021 Feb 23; Vol. 16 (2), pp. e0247275. Date of Electronic Publication: 2021 Feb 23 (Print Publication: 2021).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    COVID-19 Drug Treatment*
    Antibodies, Monoclonal, Humanized/*therapeutic use
    SARS-CoV-2/*pathogenicity
    Aged ; Cohort Studies ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Multicenter Studies as Topic ; Retrospective Studies ; SARS-CoV-2/drug effects ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab
    Autorzy:
    Franceschini, EricaAff1, IDs15010023020392_cor1
    Pellegrino, Mariachiara
    Todisco, Vera
    Dolci, Giovanni
    Bettelli, Francesca
    Meschiari, Marianna
    Bedini, Andrea.
    Fregni-Serpini, Giulia
    Grottola, Antonella
    Guaraldi, Giovanni
    Pecorari, Monica
    Sarti, Mario
    Luppi, Mario
    Perno, Carlo Federico
    Mussini, Cristina
    Pokaż więcej
    Źródło:
    Infection: A Journal of Infectious Diseases. 51(5):1577-1581
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study.
    Autorzy:
    Coloretti, Irene
    Busani, Stefano
    Biagioni, Emanuela
    Venturelli, Sophie
    Munari, Elena
    Sita, Marco
    Dall'Ara, Lorenzo
    Tosi, Martina
    Clini, Enrico
    Tonelli, Roberto
    Fantini, Riccardo
    Mussini, Cristina
    Meschiari, Marianna
    Guaraldi, Giovanni
    Cossarizza, Andrea
    Alfano, Gaetano
    Girardis, Massimo
    Modena Covid-19 Working Group*
    Pokaż więcej
    Temat:
    ADULT respiratory distress syndrome
    ARTIFICIAL respiration
    HOSPITAL patients
    SARS-CoV-2
    COVID-19
    COHORT analysis
    Źródło:
    Multidisciplinary Respiratory Medicine; 12/29/2021, Vol. 16, p1-7, 7p
    Terminy geograficzne:
    MODENA (Italy)
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Author Correction: Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection.
    Autorzy:
    De Biasi, Sara
    Tartaro, Domenico Lo
    Gibellini, Lara
    Paolini, Annamaria
    Quong, Andrew
    Petes, Carlene
    Awong, Geneve
    Douglas, Samuel
    Lin, Dongxia
    Nieto, Jordan
    Galassi, Francesco Maria
    Borella, Rebecca
    Fidanza, Lucia
    Mattioli, Marco
    Leone, Chiara
    Neri, Isabella
    Meschiari, Marianna
    Cicchetti, Luca
    Iannone, Anna
    Trenti, Tommaso
    Pokaż więcej
    Temat:
    SARS-CoV-2
    PREGNANT women
    INFLAMMATION
    INFECTION
    Źródło:
    Nature Communications; 9/27/2021, Vol. 12 Issue 1, p1-1, 1p
    Czasopismo naukowe
    Szczegóły
      Wyświetlanie 1-19 z 19

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies